{
    "code": "02004251",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02004251",
    "time": "2020-02-25 08:26:53",
    "許可證字號": "衛署藥輸字第004251號",
    "註銷狀態": "已註銷",
    "註銷日期": "88\/10\/25",
    "註銷理由": "未展延而逾期者",
    "製造許可登錄編號": "",
    "有效日期": "74\/04\/26",
    "發證日期": "65\/04\/26",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00200425102",
    "中文品名": "泰平注射液",
    "英文品名": "DAIPIN INJECTION",
    "適應症": "胃潰瘍、胃炎、十二指腸潰瘍、十二指腸炎、腸疝痛、膽管、尿路痙攣",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "METHSCOPOLAMINE METHYLSULFATE",
    "限制項目": "02輸　入",
    "申請商名稱": "0703601100  伸益興股份有限公司",
    "申請商地址": "台北巿松江路１６４巷４３號",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0035000  DAIICHI PHARMACEUTICAL CO., LTD.",
            "製造廠廠址": "14-10, NIHONBASHI, 3-CHOME, CHUO-KU, TOKYO, JAPAN.",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208003310",
            "成分名稱": "METHSCOPOLAMINE METHYLSULFATE",
            "含量描述": "0.6",
            "含量": "0.6000000000",
            "單位": "MG"
        }
    ]
}